← Back to headlines
Isomorphic Labs Raises $2.1 Billion for AI Drug Discovery
Isomorphic Labs, a DeepMind spinout backed by Google, has successfully raised $2.1 billion to advance its efforts in AI-driven drug discovery. The substantial funding aims to scale its cutting-edge research in developing new medicines.
12 May, 15:21 — 12 May, 16:17
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (42/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center2
Center (2)
marketwatchbloomberg
Right1
Right (1)
channel-news-asia
Far R
Geographic diversity— 2 regions9/34
US2Singapore1
Sources
Showing 2 of 3 sources
marketwatchMostly Factual15d ago
Google AI legend raises big money for startup targeting this cutting-edge goal
Demis Hassabis is the co-founder and CEO of Google’s DeepMind artificial-intelligence lab, which has spun out a startup called Isomorphic Labs to use AI to accelerate the creation of new drugs.
By William Gavin
Read full article →channel-news-asiaMostly Factual15d ago
Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery
Read full article →Coverage Timeline
First report: bloomberg · 12 May, 13:15|Full coverage: 3 · 3h|Window: 3h
Left-leaningCenterRight-leaning
